Scientific Program

17:30 – 19:00 Opening session Chairs: Vedat Hamuryudan (TR),
Simona Rednic (RO)
17:30 – 18:00 Rheumatology in Romania Simona Rednic (RO)
18:00 – 19:00 Rheumatology in Turkey Vedat Hamuryudan (TR)
19:00 – 21:00 Poster Presentation Tour – 1 Chairs: Suleyman Ozbek (TR),
Levan Shalamberidze (GE)
PP-01 An alternative approach to spondyloarthritis treatment: Pamidronate case series Zeynep Toker Dincer (TR)
PP-02 Isotretinoin Induced Back Pain Mimicking Ankylosing Spondylitis Oguz Gurler (TR)
PP-03 Psychometric Properties of Screening Instruments for Psoriatic Arthritis Ayse Ozdede (TR)
PP-04 Miscellaneous cause of unilateral sacroiliitis Elena Juganaru (RO)
PP-05 COVID-19, a novel trigger in ANCA-associated vasculitis Elena Juganaru (RO)
PP-06 Refractory dermatomyositis as initial presentation of lymphoma Elena Juganaru (RO)
PP-07 A case report: Yersinia enterocolitica-associated erythema multiforme and reactive arthritis Neslihan Gokcen (TR)
PP-08 A rare entity: IgG4-Related Disease mimicking cholangiocarcinoma Berna Yurttaş (TR)
PP-09 Seronegative arthritis in multiple myeloma mimicking rheumatoid arthritis Berna Yurttaş (TR)
PP-10 A case of polyarteritis nodosa with atypical presentation Erdinç Ünaldı (TR)
08:00 – 09:20 Session 1: Rheumatoid Arthritis Chairs: Timucin Kasifoglu (TR),
Catalin Codreanu (RO), Ismail Sari (TR)
08:00 – 08:15 Pain landscape in Rheumatoid Arthritis Florian Berghea (RO)
08:15 – 08:30 The role of antibodies in rheumatoid arthritis – diagnosis and monitoring Elena Rezus (RO)
08:30 – 08:50 Preclinical rheumatoid arthritis: Should we treat it? Gokhan Keser (TR)
08:50 – 09:10 A 2023 update in RA management: What is new? Catalin Codreanu (RO)
09:10 – 09:20 Discussion
09:20 – 10:30 Session 2: Spondiloarthritides Chairs: Umut Kalyoncu (TR),
Fatos Onen (TR)
09:20 – 09:40 From Pathogenic Aspects to Therapeutic Approaches in Psoriatic Arthritis Andra Balanescu (RO)
09:40 – 10:00 Axial spondyloarthritis: What’s new in diagnosis and imaging? Servet Akar (TR)
10:00 – 10:20 Axial spondyloarthritis: from Pathogenesis to Therapeutic Stategies Laura Muntean (RO)
10:20 – 10:30 Discussion
10:30 – 10:50 Coffee Break
10:50 – 12:00
Oral presentations (I) Chairs: Melike Melikoglu (TR),
Elena Rezus (RO)
10:50 – 11:00 A Nation-wide study: Prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis Hasan Satış (TR)
11:00 – 11:10 Factors related to radiographic progression in patients with rheumatoid arthritis-related interstitial lung disease Mustafa Ekici (TR) (Online)
11:10 – 11:20 Determination of underlying rheumatic diseases in patients referred to the rheumatology clinic with intrestitial lung disease: One-center experience Bilgin Karaalioğlu (TR)
11:20 – 11:30 Disease activity in Takayasu arteritis: when biomarkers fail Andreea Cioltean (RO)
11:30 – 11:40 A new player in ANCA-associated vasculitis evaluation: Patient-reported outcomes (AAV-PRO): Real-life experience Emre Bilgin (TR)
11:40 – 11:50 Evaluation of ACR / EULAR 2022 Vasculitis Classification Criteria in a single center cohort with long term follow-up: The impact of reclassification Burak Ince (TR)
11:50 – 12:00 Physical exercise in inflammatory idiopathic myositis Daisy Ana Maria Vaida Voevod (RO)
12:00 – 12:30 Satellite Symposia (I) – UCB Pharma, Romania Chair: Simona Rednic (RO)
  Because she can. Treat earlier today, for her tomorrow. Cimzia Laura Muntean (RO)
12:30 – 13:30 Lunch
13:30 – 15:00 Session 3: Connective Tissue Diseases Chairs: Yasemin Yalcinkaya (TR),
Andra Balanescu (RO), Sule Yasar Bilge (TR)
13:30 – 13:50 Recent advances in the pathogenesis of autoimmunity Guher Saruhan Dieskeneli (TR)
13:50 – 14:10 Ultrasound characteristics in patients with Sjögren’s syndrome and salivary gland lymphoma Maria Magdalena Tamas (RO)
14:10 – 14:30 The role of capilaroscopy in diagnosis and monitoring of connective tissue diseases Ileana Filipescu (RO)
14:30 – 14:50 Cardiac Involvement in Systemic Sclerosis Iulia Szabo (RO)
14:50 – 15:00 Discussion
15:00 – 15:30 Satellite Symposia (II) – Novartis Pharma, Romania Chair: Simona Rednic (RO)
  The importance of early diagnosis in axSpA Florentin Vreju (RO)
15:30 – 17:00 Session 4: Ultrasound in Rheumatology Chairs: Salih Pay (TR) (Online),
Maia Tsutkridze (GE), Hakan Emmungil (TR)
15:30 – 15:50 Ultrasound gets everything crystal clear in crystal related arthropathies Florentin Vreju (RO)
15:50 – 16:10 The utility of musculoskeletal ultrasound in low back pain (SpA) differential diagnosis and treatment decisions Plamen Todorov (BG)
16:10 – 16:30 Relevant applications of musculoskeletal ultrasonography in rheumatoid arthritis Maia Tsutskridze (GE)
16:30 – 16:50 Ultrasound of the salivary glands in Sjögren’s syndrome Nevsun Inanc (TR)
16:50 – 17:00 Discussion
17:00 – 17:15 Coffee break
17:15 – 17:55 Session 5: Inflammatory Myositis
Chairs: Yasemin Kabasakal (TR) ,
Razvan Ionescu (RO)
17:15 – 17:35 Cancer associated dermatomyositis, a challenge for the physician Magda Parvu (RO)
17:35 – 17:45 IVIG treatment for dermatomyositis Berkan Armagan (TR)
17:45- 17:55 Discussion
17:55- 18:45 Session 6: Relapsing Polychondritis -UCTD Chairs: Ahmet Omma (TR),
Magda Parvu (RO)
17:55- 18:15 Relapsing Polychondritis: An update for clinicians Simona Rednic (RO)
18:15- 18:35 UCDT in 2023: where do we stand? Cristina Pamfil (RO)
18:35- 18:45 Discussion
18:45- 19:15 Session 7: Osteoporosis  Chair: Sedat Kiraz (TR)
18:45- 19:05 Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment Siao pin Simon (RO)
19:05 – 19:15 Discussion
08:30 – 09:40 Session 8: Connective Tissue Diseases (II) Chairs: Veli Yazisiz (TR),
Maria Magdalena Tamas (RO)
08:30 – 08:50 What has changed with the new Pulmonary hypertension guideline? Alper Sari (TR)
08:50 – 09:10 Turkish Society for Rheumatology treatment recommendations for Systemic Sclerosis associated digital ulcers Duygu Temiz Karadag (TR)
09:10 – 09:30 Systemic Lupus Erithematosus: Emerging therapies Murat Inanc (TR)
09:30 – 09:40 Discussion
09:40 – 10:30 Session 9: JAK Inhibitors  Chairs: Ihsan Ertenli (TR),
Siao pin Simon (RO)
09:40 – 10:00 JAK inhibitors in the treatment of Spondyloarthritides Pamir Atagunduz (TR)
10:00 – 10:20 Safety of JAK inhibitors Abdulsamet Erden (TR)
10:20 – 10:30 Discussion
10:30 – 11:00 Coffee break
11:00 – 12:00 Oral presentations (II) Chairs: İzzet Fresko (TR),
Ileana Filipescu (RO)
11:00 – 11:10 Evaluation of HLA-B7 in Axial Spondylarthritis Gökhan Sargın (TR)
11:10 – 11:20 Frequency Of Scolıosıs In Axıal Spondyloarthrıtıs Patıents Duygu Sevinç Özgür (TR)
11:20 – 11:30 Difficult-To-Treat definition and risk factors in Axial Spondyloarthropathy Patients Tahir Saygın Öğüt (TR)
11:30 – 11:40 The impact of 6-month delay in diagnosis on clinical and functional status in the PsA patients under bDMARD treatment: Results from TReasure database Gizem Ayan (TR)
11:40 – 11:50 Impact of Chronic Kidney Disease in Patients with AS Using Biologic Agents: HURBIO single center registry Gül Sandal Uzun (TR) (Online)
11:50 – 12:00 VEXAS Syndrome: A Novel Somatic Mutation Disease, Hacettepe University Experience Ertugrul Cagri Bolek (TR)
12:00 – 13:30 Lunch
13:30 – 14:40 Session 10: Autoinflammatory diseases Chairs: Suleyman Serdar Koca (TR),
Laura Damian (RO)
13:30 – 13:50 Current treatment of adult onset Still’s disease Kenan Aksu (TR)
13:50 – 14:10 Update on the diagnosis and treatment of FMF Ahmet Gul (TR) (Online)
14:10 – 14:30 Gout: from pathogenesis to treatment Ender Terzioglu (TR) (Online)
14:30 – 14:40 Discussion
14:40 – 16:00 Session 11: Vasculitides Chairs: Gulen Hatemi (TR),
Cristina Pamfil (RO)
14:40 – 15:00 2022 ACR/EULAR GCA/EGPA/MPA Calassification Criteria: Strengths and limitations Omer Karadag (TR)
15:00 – 15:20 Recent advances in the management of Takayasu’s disease Fatma Alibaz (TR)
15:20 – 15:40 Update in the management of Behçet’s syndrome Haner Direskeneli (TR)
15:40 – 16:00 Discussion
16:00 – 16:30 Coffee break
16:30 – 18:00 Difficult case presentations Chairs: Cemal Bes (TR),
Laura Muntean (RO)
16:30 – 16:45 Challenges of preconception management in a lupus nephritis patient Stefan Neculai Nica (RO)
16:45 – 17:00 Anti-U1RNP antibodies associated with irreversible organ damage in a lupus erythematosus patient Teodora Baciu (RO)
17:00 – 17:15 Neurological manifestations in systemic lupus erytemathosus: a case with an individualized therapeutic approach Cristina Elena Nita (RO)
17:15 – 17:30 Juvenile idiopathic arthritis or something else? Violeta Zanfir (RO)
17:30 – 17:45 Pyomyositis in a diabetic patient with active ankylosing spondylitis Elena Juganaru (RO)
17:45 – 18:00 Important lessons in dealing with a complicated case Anca Roxana Gherasim (RO)
09:00 – 12:00 Poster Presentation Tour – 2 Chairs: Suleyman Ozbek (TR),
Levan Shalamberidze (GE)
PP-11 A case of Hidradenitis Suppurativa and Amyloidosis Hakan Babaoğlu (TR)
PP-12 Clinical significance of non-criteria antiphospholipid antibodies in antiphospholipid syndrome Pınar Akyüz Dağlı (TR)
PP-13 A Mortal Case of Granulomatous Polyangiitis with Taenia saginata and Hemorrhagic Bullous Lesions Belkıs Nihan Coşkun (TR)
PP-14 The other side of cancer immunotherapy – Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Hypertrophic Osteoarthropathy Anamaria Marian (RO)
PP-15 Complicated Case: Management of pyoderma gangrenosum in a patient with juvenile dermatomyositis Bahar Özdemir Ulusoy (TR)
PP-16 Important Mimic of Rheumatological Diseases; Infective Endocarditis Alican Karakoç (TR)
PP-17 Connective tissue diseases and Multiple sclerosis Selime Ermurat (TR)
PP-18 dress syndrome due to anti rheumatic drug Adem Küçük (TR)
PP-19 In the midst of the COVID-19 pandemic, an uncommon differential diagnosis presents itself: the Anti-synthetase syndrome Busra Firlatan (TR)
PP-20 Granulomatous polyangiitis with cranial involvement: Case presentation Gözde Sevgi Kart Bayram (TR)
PP-21 A Rare Presentation of Systemic Lupus Erythematosus: The Coexistence of Kore and Libman Sax Endocarditis Fatih Saritas(TR)
12:00 – 13:00 Closing
Abbreviations: RO: Romania / TR: Turkiye / GE: Georgia / BG: Bulgaria

Registration Is Open
Black Sea Rheumatology 2023 registration is now open. Limited places available, you can register with the early-bird fees on 1st period, by February 17, 2023

Abstract Submission
Abstract submission is now open for the Black Sea Rheumatology 2023. Deadline for abstract submission is March 19, 2023. We are pleased to invite authors to submit their abstracts for early review.
Submit Your Abstract

Industry Engagement
We have created a variety of packages to provide you with a successful experience at Black Sea Rheumatology. We are committed to providing the information and tools you need as you plan for the meeting.

May 18, 2023 |  First Day of the Congress
February 17, 2023 |  Early-Bird Registration
March 19, 2023 | Deadline for Abstract Submission

About Black Sea Rheumatology

“Black Sea Rheumatology” project consists of a series of meetings to be held in countries of the Black Sea basin.

These meetings aim to establish scientific connections between these countries by bringing together basic and clinical scientists interested in rheumatology.

The scientific program will include lectures on basic and clinical research as well as treatment of common and regional rheumatic diseases, oral presentations and discussions.


Organizing Secretariat

Please contact organizing secretariat for your registration & accommodation requests.
Professional Congress Organizer (PCO)
D Event Tourism Organization
İçerenköy Mah. Çayır Cad. No:5 Bay Plaza Kat:12
Ataşehir, İstanbul
  Phone: +90 216 573 18 36
  Instagram: @blacksearheumatology

© 2023 Black Sea Rheumatology